New Windsor, NY, United States of America

Lawrence Nathan Tumey

This inventor holds 15 USPTO granted patents and 10 published patent applications, plus 4 CIPO patents and 3 EPO patents. Top assignees: Pfizer Corporation, Wyeth, Athersys, Inc.. Active years: 2008-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lawrence Nathan Tumey. Retrieved from https://idiyas.com/inventor/lawrence-nathan-tumey

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 (Patent Applications = 10)

% Patents Active = 53.3

CIPO Patents = 4 (Patent Applications = 4)

EPO Patents = 3 (Patent Applications = 7)

Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 25(Granted Patents)

Location History:

Fairview Park, OH (US) (2008 - 2010)
New Windsor, NY (US) (2009 - 2011)
Vestal, NY (US) (2020 - 2023)
Pawcatuck, CT (US) (2020 - 2024)

Company Filing History:

Years Active: 2008-2024

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11993625 - Calicheamicin derivatives and antibody drug conjugates thereof (2024-05-28),

2. 11712480 - Heteroaryl sulfone-based conjugation handles, methods for their preparation, and their use in synthesizing antibody drug conjugates (2023-08-01),

3. 11613581 - Antibodies and antibody-drug conjugates specific for CD123 and uses thereof (2023-03-28),

4. 11365263 - Bifunctional cytotoxic agents containing the CTI pharmacophore (2022-06-21),

5. 11364303 - Cysteine engineered antibody drug conjugates (2022-06-21),

6. 10870706 - Bifunctional cytotoxic agents containing the CTI pharmacophore (2020-12-22),

7. 10723727 - Tubulysin analogs and methods for their preparation (2020-07-28),

8. 7981912 - Indole acetic acids exhibiting CRTH2 receptor antagonism and uses thereof (2011-07-19),

9. 7947691 - Cyclic n-hydroxy imides as inhibitors of flap endonuclease and uses thereof (2011-05-24),

10. 7781591 - Substituted 3-cyanopyridines as protein kinase inhibitors (2010-08-24),

11. 7732618 - Benzimidazole acetic acids exhibiting CRTH2 receptor antagonism and uses thereof (2010-06-08),

12. 7718647 - Substituted azepine derivatives as serotonin receptor modulators (2010-05-18),

13. 7601749 - Indole acetic acids exhibiting CRTH2 receptor antagonism and uses thereof (2009-10-13),

14. 7476667 - Indole acetic acids exhibiting CRTH2 receptor antagonism and uses thereof (2009-01-13),

15. 7405215 - Indole acetic acids exhibiting CRTH2 receptor antagonism and uses thereof (2008-07-29),

Title: The Innovations of Lawrence Nathan Tumey

Introduction

Lawrence Nathan Tumey is a notable inventor based in New Windsor, NY, USA. He holds an impressive portfolio of 8 patents, reflecting his significant contributions to the field of science and technology. Tumey's inventions primarily revolve around pharmaceutical compounds and their applications in treating various disorders.

Latest Patents

Among Tumey's latest patents is the invention of "Indole acetic acids exhibiting CRTH2 receptor antagonism and uses thereof." This groundbreaking work relates to indole acetic acid compounds that function as antagonists of the CRTH2 receptor, which are utilized to inhibit the binding of prostaglandin D and its metabolites, as well as certain thromboxane metabolites. This inhibition is crucial for treating disorders responsive to these mechanisms. Another notable patent is for "Cyclic n-hydroxy imides as inhibitors of flap endonuclease and uses thereof." This invention details acrylic n-hydroxy imides and their potential use in pharmaceutical compositions to inhibit flap endonuclease, adding to the toolbox of therapeutic options in medicine.

Career Highlights

Throughout his career, Lawrence Nathan Tumey has worked with several prominent companies in the pharmaceutical industry, including Wyeth and Athersys, Inc. His experience in these esteemed organizations has undoubtedly shaped his innovative outlook and understanding of the complexities involved in drug development and patenting.

Collaborations

During his career, Tumey collaborated with talented professionals in his field, including Youssef L Bennani and Michael J Robarge. These collaborations reflect his commitment to advancing research and innovation through teamwork and shared expertise.

Conclusion

Lawrence Nathan Tumey's journey as an inventor is marked by a strong record of innovation and impactful contributions to science. His patents exemplify the potential of pharmaceutical research, with applications that can lead to breakthroughs in treating various diseases. As he continues to innovate, Tumey remains a vital figure in the landscape of modern inventions.

Profile summary based on public USPTO records.